New Fertility Test Uses Menstrual Blood for Uterine Health Assessment

A non-invasive fertility test analyzing menstrual blood for molecular markers is under development by Genie Fertility, a startup that recently secured $1.22 million (£908,000) in pre-seed funding from European and US investors. This innovative approach aims to provide a more accurate and accessible assessment of uterine health than traditional methods.

The Limitations of Current Uterine Health Assessments

Currently, assessing the uterine lining requires a biopsy – a procedure that is both invasive and expensive. Critically, biopsies only sample a small portion of the uterine lining, potentially missing crucial information about overall uterine health. This limited sampling can affect the accuracy of the assessment.

How the New Test Works

Genie Fertility’s test analyzes menstrual blood, which contains a wealth of reproductive health data not found in standard blood samples. Menstrual blood represents the shedding of the entire uterine lining, offering a more comprehensive snapshot of uterine health. The company utilizes a machine learning platform to identify key molecular markers within the menstrual blood sample.

Addressing a Gap in Women’s Reproductive Health Research

Dr. Andreas Hadjimitsis, Genie’s chief technology officer, highlights a significant gap in understanding women’s reproductive health. He notes that limited research and a general lack of accessibility to the uterus have contributed to this knowledge deficit. The development of this test is partially driven by a need to address this historical underrepresentation in research.

Focus on IVF Support

The initial application of this technology is a fertility test designed to support women undergoing in vitro fertilization (IVF). The test provides doctors with information about the health of the uterus, enabling them to optimize treatment plans and potentially increase conception rates. Heavy or scant menses can often reflect underlying issues impacting fertility, making accurate uterine assessment crucial.

Menstrual Characteristics and Fertility

Menstruation is a key indicator of a woman’s reproductive well-being and plays a significant role in fertility. Research continues to explore the correlation between menstrual characteristics and fertility outcomes.

The Future of Reproductive Health Data

The development of this test aligns with a growing trend of utilizing menstrual blood for reproductive health data analysis. Genie Fertility’s approach represents a shift towards non-invasive methods for gathering valuable insights into uterine health and improving fertility treatments.

Conception Challenges and Patient Support

Clinicians play a vital role in supporting patients facing conception challenges, providing counseling, personalized care, and awareness of emerging fertility resources. Understanding hormones and fertility is crucial for effective patient management.